IGF1R plays a role in differentiation of hematopoietic cells and appears to regulate BCR–ABL leukemia cell fate and self-renewal in chronic myeloid leukemia (CML) cells (Xie et al. 2015). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.